Leading health bodies publish joint safety alert on HRT prescribing 

The statement says that the increasing number of women being prescribed high doses of oestrogen is not in line with any clinical guideline.
Circular dispenser of HRT tablets
The safety alert warns that oestrogen should not be regularly prescribed in doses higher than the upper limit listed in the individual summary of product characteristics

STEVE HORRELL / SCIENCE PHOTO LIBRARY

Six leading UK health bodies have published a joint safety alert in response to concerns about requests from private clinics to prescribe high doses of oestrogen, outside of product licence, sometimes with insufficient progestogen, for women experiencing symptoms of the menopause.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated